These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 3604854
1. Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias. Hohnloser SH, Raeder EA, Podrid PJ, Graboys TB, Lown B. Am Heart J; 1987 Jul; 114(1 Pt 1):1-7. PubMed ID: 3604854 [Abstract] [Full Text] [Related]
2. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD. J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243 [Abstract] [Full Text] [Related]
3. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease. Meissner MD, Kay HR, Horowitz LN, Spielman SR, Greenspan AM, Kutalek SP. Am J Cardiol; 1988 May 01; 61(13):1050-5. PubMed ID: 3284319 [Abstract] [Full Text] [Related]
4. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia. Platia EV, Estes M, Heine DL, Griffith LS, Garan H, Ruskin JN, Reid PR. Am J Cardiol; 1985 Apr 01; 55(8):956-62. PubMed ID: 3984883 [Abstract] [Full Text] [Related]
5. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study. Buxton AE, Marchlinski FE, Flores BT, Miller JM, Doherty JU, Josephson ME. Circulation; 1987 Jun 01; 75(6):1178-85. PubMed ID: 3568327 [Abstract] [Full Text] [Related]
6. Antiarrhythmic efficacy and hemodynamic effects of cibenzoline in patients with nonsustained ventricular tachycardia and left ventricular dysfunction. Seals AA, Haider R, Leon C, Francis M, Young JB, Roberts R, Pratt CM. Circulation; 1987 Apr 01; 75(4):800-8. PubMed ID: 3549044 [Abstract] [Full Text] [Related]
7. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs. Kienzle MG, Martins JB, Wendt DJ, Constantin L, Hopson R, McCue ML. Am J Cardiol; 1988 May 01; 61(13):1012-7. PubMed ID: 3129926 [Abstract] [Full Text] [Related]
8. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation. Anderson JL, Reid PR, Platia EV, Akhtar M, Ruskin JN, Schaal SF, Jueng P, Long RA, Wenger TL. Am Heart J; 1985 Oct 01; 110(4):774-84. PubMed ID: 3901715 [Abstract] [Full Text] [Related]
10. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone. McGovern B, Garan H, Malacoff RF, DiMarco JP, Grant G, Sellers TD, Ruskin JN. Am J Cardiol; 1984 Jun 01; 53(11):1558-63. PubMed ID: 6731300 [Abstract] [Full Text] [Related]
11. Comparison of programmed electrical stimulation and ambulatory electrocardiographic (Holter) monitoring in the management of ventricular tachycardia and ventricular fibrillation. Platia EV, Reid PR. J Am Coll Cardiol; 1984 Sep 01; 4(3):493-500. PubMed ID: 6470328 [Abstract] [Full Text] [Related]
12. Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure. Brodsky MA, Allen BJ, Abate D, Henry WL. Am Heart J; 1985 Oct 01; 110(4):794-9. PubMed ID: 4050651 [Abstract] [Full Text] [Related]
13. Propafenone: noninvasive evaluation of efficacy. Podrid PJ, Cytryn R, Lown B. Am J Cardiol; 1984 Nov 14; 54(9):53D-59D. PubMed ID: 6496369 [Abstract] [Full Text] [Related]
14. Prognostic assessment of survivors of ventricular tachycardia and ventricular fibrillation with ambulatory monitoring. Vlay SC, Kallman CH, Reid PR. Am J Cardiol; 1984 Jul 01; 54(1):87-90. PubMed ID: 6741843 [Abstract] [Full Text] [Related]
15. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome. Bhandari AK, Hong R, Au P, McKay CR, Rahimtoola SH. Can J Cardiol; 1988 Mar 01; 4(2):80-4. PubMed ID: 3365601 [Abstract] [Full Text] [Related]
16. Surgical management of sustained ventricular arrhythmias presenting within eight weeks of acute myocardial infarction. Kron IL, Lerman B, DiMarco JP. Ann Thorac Surg; 1986 Jul 01; 42(1):13-6. PubMed ID: 3729611 [Abstract] [Full Text] [Related]
17. Serial electrophysiological testing of antiarrhythmic drug efficacy in patients with recurrent ventricular tachycardia. Breithardt G, Seipel L, Abendroth RR, Loogen F. Eur Heart J; 1980 Feb 01; 1(1):11-24. PubMed ID: 7026245 [No Abstract] [Full Text] [Related]
18. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts. Kuchar DL, Garan H, Venditti FJ, Finkelstein D, Rottman JN, McComb J, McGovern BA, Ruskin JN. Am J Cardiol; 1989 Jul 01; 64(1):33-6. PubMed ID: 2741811 [Abstract] [Full Text] [Related]
19. The signal averaged electrocardiogram and programmed stimulation in patients with complex ventricular arrhythmias. Turitto G, el-Sherif N. Pacing Clin Electrophysiol; 1990 Dec 01; 13(12 Pt 2):2156-9. PubMed ID: 1704610 [Abstract] [Full Text] [Related]
20. Incidence and timing of recurrences of sudden death and ventricular tachycardia during antiarrhythmic drug treatment after myocardial infarction. Rodriguez LM, Smeets J, O'Hara GE, Geelen P, Brugada P, Wellens HJ. Am J Cardiol; 1992 Jun 01; 69(17):1403-6. PubMed ID: 1590227 [Abstract] [Full Text] [Related] Page: [Next] [New Search]